Your browser doesn't support javascript.
loading
Efficacy of cognitive behavioral therapy for menopausal symptoms and quality of life in Korean perimenopausal women: A pilot randomized controlled trial.
Kim, Da Seul; Kim, Na Yeon; Han, Doug Hyun; Kim, Hee Jun; Yu, Eun Seung; Kim, Sun Mi.
Afiliación
  • Kim DS; Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Kim NY; Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Han DH; Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Kim HJ; Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Yu ES; Department of Counseling Psychology, The Cyber University of Korea, Seoul, Republic of Korea.
  • Kim SM; Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Electronic address: sunmikim706@cauhs.or.kr.
Maturitas ; 189: 108103, 2024 Nov.
Article en En | MEDLINE | ID: mdl-39190949
ABSTRACT

OBJECTIVES:

Therapeutic interventions are crucial for perimenopausal women, given the challenging physical and psychological symptoms they face. This study focused on the development and verification of the efficacy of a cognitive behavioral therapy (CBT) protocol designed specifically for Korean perimenopausal women. STUDY

DESIGN:

A CBT protocol for perimenopausal women was newly developed based on theory and evidence. Forty menopausal women were randomly assigned to either the CBT group (n = 19) or treatment-as-usual (TAU) group (n = 21). Participants in the CBT group underwent 60-min weekly sessions for eight weeks. The TAU group received standard care from gynecologists. MAIN OUTCOME

MEASURES:

At baseline and follow-up, participants completed the Menopausal Rating Scale (MRS), World Health Organization Quality of Life Brief Version (WHOQOL-BREF), Patient Health Questionnaire-9, Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-15 (PHQ-15), Menopause Emotional Symptom Questionnaire (MESQ), and Subjective Memory Complaints Questionnaire.

RESULTS:

The CBT group showed significant changes in their MRS (F = 4.18, p = .048), WHOQOL-BREF (7.60, 0.009), GAD-7 (4.61, 0.038), PHQ-15 (5.49, 0.025), and MESQ scores (7.19, 0.011) compared to the TAU group. In the CBT group, changes in GAD-7 scores were correlated with PHQ-15 (ρ = 0.57, p < .05), MESQ (0.57, < 0.05), and WHOQOL-BREF scores (-0.53, < 0.05).

CONCLUSION:

CBT prevents the worsening of menopausal and emotional symptoms, anxiety, and quality of life. CBT may have had a therapeutic effect through the following mechanisms managing anxiety by changing perceptions of menopause through education and training for coping with various menopausal symptoms and improving self-efficacy in symptom management. CLINICAL TRIAL REGISTRATION NUMBER KCT0007517.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Terapia Cognitivo-Conductual / Perimenopausia Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Maturitas Año: 2024 Tipo del documento: Article Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Terapia Cognitivo-Conductual / Perimenopausia Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Maturitas Año: 2024 Tipo del documento: Article Pais de publicación: Irlanda